GeneMe

Executive Summary

GeneMe is a Polish biotechnology company founded in 2015 and headquartered in Warsaw, specializing in direct-to-consumer (DTC) genetic testing services. The company analyzes DNA to provide personalized health and ancestry reports, positioning itself in the growing market for consumer genomics. With a focus on translating genetic data into actionable insights, GeneMe aims to empower individuals to make informed health decisions. The diagnostics sector, particularly in Europe, is seeing increased demand for preventive and personalized healthcare solutions, favorable tailwinds for GeneMe's business model.

Upcoming Catalysts (preview)

• Q4 2026Launch of new genetic test panel (e.g., pharmacogenomics or trait analysis)60% success
• H1 2026Strategic partnership with a healthcare provider or pharmaceutical company40% success
• Q2 2026Series A funding round to accelerate product development and market expansion50% success